Data from EMC - Curated by Toby Galbraith - Last updated 15 March 2017

Licensing authority

EMA (European Medicines Agency)

Indication(s)

Treatment of essential hypertension.

Copalia is indicated in adults whose blood pressure is not adequately controlled on amlodipine or valsartan monotherapy.

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Acute and Advanced Heart Failure

What are the most effective treatments for acute heart failure? Can you define advanced heart failure? Discover here...

Visit Acute and Advanced Heart Failure


Bedwetting

Essential screening, diagnosis and best strategies to manage bedwetting

Visit Bedwetting


Related Content

More information

Category Value
Agency product number EMEA/H/C/000774
Orphan designation No
Date First Approved 16-01-2007
Type POM
Marketing authorisation holder Novartis Europharm Ltd